{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "RSCN1",
        "Protein_Change": {
          "ref": "G",
          "alt": "T",
          "position": "534"
        },
        "variant_string_id": "RSCN1 G534T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that PD is linked to mitochondrial dysfunction, and the A53T mutation in R-syn is associated with increased levels in PD.",
          "judgment": "Yes",
          "reasoning": "The abstract explicitly links the A53T mutation to PD through mitochondrial dysfunction, aligning with the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "The study used 2D in-gel electrophoresis and Western blot to detect protein changes in mitochondria from SH-SY5Y cells overexpressing WT or A53T R-syn.",
          "judgment": "Yes",
          "reasoning": "The assays are relevant to mitochondrial function, directly addressing PD pathogenesis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper confirmed altered protein expression using LC-MS/MS and Western blot for four mitochondrial proteins (HSPA9, NDUFS1, DLAT, ATP5A1), with statistical significance (p < 0.01).",
          "judgment": "Yes",
          "reasoning": "Basic controls (WT vs. A53T) and replicates were used, and the results were statistically significant, validating the assay."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The study found 63 proteins with >1.8/<-1.01 fold change, 77% altered in WT samples, and four mitochondrial proteins confirmed by Western blot.",
          "judgment": "Yes",
          "reasoning": "Statistical significance (p < 0.01) and multiple assay validations support the OddsPath calculation for the A53T variant."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_evidence": "Strong evidence from multiple assays and statistical significance confirms the A53T mutation in R-syn is pathogenic, aligning with PD pathology."
    }
  ]
}